title: [The antimicrobial effect of lysozyme on nasal mucosa].
abstract: We tested the effect of lysozyme on the nasal mucosa in a controlled double-blind in vivo study. The administration of non-pathogenic vaccine strains of living measles virus and of living Vivotif bacteria (attenuated Salmonella typhi) to 14 healthy subjects showed that lysozyme possesses a clear antimicrobial and antiviral effect.
authors.affiliation: Universitätsklinik für HNO-Krankheiten, Kantonsspital Basel.
authors.forename: U
authors.initials: U
authors.lastname: Glück
mesh_terms: D000281:Administration, Intranasal; D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D008459:Measles virus / Q000187:drug effects*; D009113:Muramidase / Q000494:pharmacology*; D009297:Nasal Mucosa / Q000382:microbiology*; D012485:Salmonella typhi / Q000187:drug effects*
chemical_list: D009113:Muramidase
vernacular_title: Zur antimikrobiellen Wirkung von Lysozym auf der Nasenschleimhaut.